author-photo

Maria Riemma

4

Papers

5

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

CDK 4/6 inhibitors (CDKi) + endocrine therapy (ET) in ER-positive metastatic breast cancer (mBC) patients according ET sensitivity: A systematic review and meta-analysis.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PerTe: Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer patients—Efficacy and safety of pertuzumab in “real life" setting.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)